High dose cyclophosphamide in the treatment of systemic lupus erythematosus
Mittal, G.; Balakrishnan, C.; Mangat, G.; Joshi, V.R.
Journal of the Association of Physicians of India 47(7): 747
1999
ISSN/ISBN: 0004-5772 PMID: 10778607 Document Number: 505669
Document emailed within 1 workday
Related Documents
Leung, F.K.; Fortin, P.R. 2003: Intravenous cyclophosphamide and high dose corticosteroids improve MRi lesions in demyelinating syndrome in systemic lupus erythematosus Journal of Rheumatology 30(8): 1871-1873Winder, A.; Molad, Y.; Ostfeld, I.; Kenet, G.; Pinkhas, J.; Sidi, Y. 1993: Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases Journal of Rheumatology 20(3): 495-498
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Yang, X.; Yin, P.; Gao, X. 1996: A study on interval of intravenous cyclophosphamide pulse in the treatment of severe systemic lupus erythematosus Zhonghua Nei Ke Za Zhi 35(4): 257-260
Ichikawa, Y.; Yamada, H.; Tanaka, H.; Yoshida, T. 1994: Cyclophosphamide pulse therapy in systemic lupus erythematosus Ryumachi 34(3): 675-683
Anić, B.; Crkvencić, N.; Mayer, M.; Bosnić, D.; Sentić, M.; Markeljević, J.; Cikes, N. 1999: Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus Lijecnicki Vjesnik 121(9-10): 283-288
Fuks, A.; Carballal, G.; Manni, J.A. 1979: Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations Medicina 39(3): 289-297
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Groen, H.; Bootsma, H.; Postma, D.S.; Kallenberg, C.G. 1993: Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide Journal of Rheumatology 20(6): 1055-1057
Aikawa, N.E.; Sallum, A.M.E.; Pereira, R.M.R.; Suzuki, L.; Viana, V.S.T.; Bonfá, E.; Silva, C.A. 2012: Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy Clinical and Experimental Rheumatology 30(3): 445-449
Yang, X.-y.; Zhu, X.; Liang, L.-q.; Zhan, Z.-p.; Ye, Y.-j. 2005: Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy Zhonghua Yi Xue Za Zhi 85(14): 960-962
Alsufyani, K.A.; Ortiz-Alvarez, O.; Cabral, D.A.; Tucker, L.B.; Petty, R.E.; Nadel, H.; Malleson, P.N. 2005: Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise Journal of Rheumatology 32(4): 729-733
De Carvalho Valle LM; Nogueira Castanon MC; Gonçalves Da Costa PS 1998: Scabies Norwegian Associated with High IgE and Low IgG1 Levels Presenting as Systemic Lupus Erythematosus Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 2(2): 97-104
Mackworth-Young, C.; Chan, J.; Harris, N.; Walport, M.; Bernstein, R.; Batchelor, R.; Hughes, G.; Gharavi, A. 1987: High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus Journal of Rheumatology 14(4): 723-726
Carsons, S. 1987: High levels of fibronectin fragments in the plasma of a patient with active systemic lupus erythematosus Journal of Rheumatology 14(5): 1052-1054
Ivanova, M.M. 1985: Treatment of systemic lupus erythematosus Klinicheskaia Meditsina 63(1): 16-23
Chew, C.; Pemberton, P.W.; Husain, A.A.-M.; Haque, S.; Bruce, I.N. 2013: Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus Clinical and Experimental Rheumatology 31(2): 251-255
Formiga, F.; Moga, I.; Navarro, M.A.; Nolla, J.M.; Bonnin, R.; Roig-Escofet, D.; Pujol, R. 1996: Bone mineral density in female patients with systemic lupus erythematosus treated with high glucocorticoid doses Revista Clinica Espanola 196(11): 747-750
Wierzchowiecki, M. 1973: Plaquenil in treatment of systemic lupus erythematosus Polski Tygodnik Lekarski 28(47): 1866-1868
Boyer, G.S.; Templin, D.W.; Lanier, A.P. 1991: Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus Journal of Rheumatology 18(10): 1477-1484